Gestational diabetes and the incidence of type 2 diabetes: a systematic review.

By Catherine Kim, K. Newton, R. Knopp. Diabetes Care, 2002

2,268 citations recorded by the source corpus.

Subfields: Epidemiology, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/20a11b4f2023dbab4791074c0b86eb0517c79a8d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Silvio E. Inzucchi
2. I. Hirsch
3. M. S. Kirkman
4. V. Basevi
5. R. Eckel

In Obstetrics and Gynecology

1. V. Basevi
2. Silvio E. Inzucchi
3. I. Hirsch
4. M. S. Kirkman
5. Boyd E. Metzger

Citations in the corpus

• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. (2021, background): “GDM is often indicative of underlying b-cell dysfunction (220), which confers marked increased risk for later development of diabetes, generally but not always type 2 diabetes, in the mother after delivery (221,222).”
• Standards of Medical Care in Diabetes—2008 (2008, methodology): “Because women with a history of GDM have a greatly increased subsequent risk for diabetes (24), they should be screened for diabetes 6–12 weeks postpartum, using standard criteria, and should be followed up with subsequent screening for the development of diabetes or pre-diabetes, as outlined in Sec”
• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “In addition, because women with GDM are at a considerably increased risk of developing diabetes later (179), lifelong screening for diabetes should be performed at least every 3 years according to standard criteria for nonpregnant women (Table 4) (93).”
• Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review. (2013, background): “is also an important risk factor for type 2 diabetes in women [11,12].”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 (2019, background): “GDM is often indicative of underlying b-cell dysfunction (135), which confers marked increased risk for later development of diabetes, generally but not always type 2 diabetes, in the mother after delivery (136,137).”
• The metabolic syndrome. (2008, background): “The conversion of GDM into T2D varies between 6 and 92%, depending on diagnostic criteria, racial/ethnic background of the subject sample, and duration of surveillance (416).”
• Standards of Medical Care in Diabetes—2012 (2011, background): “Womenwith a history of GDMhave a greatly increased subsequent risk for diabetes (40) and should be followed up with subsequent screening for the development of diabetes or prediabetes, as outlined in section II.”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 (2017, background): “Because GDM confers increased risk for the development of type 2 diabetes after delivery (58,59) and because effective prevention interventions are available (60,61), women diagnosed with GDM should receive lifelong screening for prediabetes and type 2 diabetes.”